Liver Clinical Trial
Official title:
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
Primary Objectives: Our study will investigate the feasibility of an accelerated recovery program to minimize length of stay (LOS) and facilitate outpatient surgery for patients undergoing minimally invasive, lower complexity (Kawaguchi-Gayet grade I) liver resection. This program (ARAMIS Hep) will combine minimally invasive surgical (MIS) approaches (robotic OR laparoscopic), enhanced recovery after surgery (ERAS) protocols, and Telehealth to liberalize discharge criteria in a safe manner. Secondary Objectives: In addition to demonstrating a reduction in LOS, our study will also provide preliminary data to aid in the broader implementation of this approach. Specifically, we will gain insight into the patient experience, measure patient-reported outcomes on recovery trajectories, and understand barriers to integrating a novel pathway into existing institutional frameworks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01201096 -
Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
|
N/A | |
| Terminated |
NCT01163526 -
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
|
N/A | |
| Completed |
NCT00250796 -
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT05389241 -
Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial
|
N/A | |
| Completed |
NCT00924248 -
Primovist Regulatory Post Marketing Surveillance (PMS)
|
N/A | |
| Completed |
NCT01420211 -
Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®
|
Phase 1/Phase 2 | |
| Completed |
NCT00494312 -
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
|
Phase 4 | |
| Completed |
NCT01471080 -
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver
|
N/A | |
| Withdrawn |
NCT00718055 -
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients
|
Phase 4 | |
| Terminated |
NCT00708877 -
Liver Transplantation for Cholangiocarcinoma
|
N/A | |
| Enrolling by invitation |
NCT06364865 -
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
|
||
| Recruiting |
NCT00343122 -
Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline
|
Phase 4 | |
| Active, not recruiting |
NCT04721782 -
Effects of Maternal Smoking on Fetal Liver Circulation
|
||
| Recruiting |
NCT03881306 -
DEBOXA for Inoperable NET Liver Metastases
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01143935 -
Estimation of Standard Liver Volume in the Indian Population
|
N/A | |
| Completed |
NCT00422838 -
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
|
N/A | |
| Completed |
NCT03876574 -
Hepatic Artery Infusion Pump for NPC Liver Metastases
|
Phase 1 | |
| Recruiting |
NCT06195943 -
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
|
N/A | |
| Completed |
NCT03735706 -
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.
|
N/A | |
| Not yet recruiting |
NCT06153914 -
SALT for Patients With Hepatic Cirrhosis
|
N/A |